Lundbeckfond Invest A/S 13D/13G Filings for OnKure Therapeutics, Inc. (OKUR)

Lundbeckfond Invest A/S 13D and 13G filings for OnKure Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-02-06
9:09 pm
Unchanged		2024-12-3113GONKURE THERAPEUTICS, INC. CLAS
OKUR		Lundbeckfond Invest A/S203,122
1.600%		0
(Unchanged)		Filing